Accuray Gross Margin 2012-2026 | ARAY
Current and historical gross margin for Accuray (ARAY) over the last 10 years. The current gross profit margin for Accuray as of June 30, 2026 is %.
| Accuray Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2026-06-30 | $0.40B | $0.11B | 27.86% |
| 2026-03-31 | $0.43B | $0.12B | 26.81% |
| 2025-12-31 | $0.44B | $0.12B | 27.92% |
| 2025-09-30 | $0.45B | $0.14B | 31.04% |
| 2025-06-30 | $0.46B | $0.15B | 32.03% |
| 2025-03-31 | $0.47B | $0.15B | 31.40% |
| 2024-12-31 | $0.45B | $0.14B | 31.57% |
| 2024-09-30 | $0.44B | $0.14B | 30.86% |
| 2024-06-30 | $0.45B | $0.14B | 31.84% |
| 2024-03-31 | $0.43B | $0.14B | 33.02% |
| 2023-12-31 | $0.45B | $0.15B | 34.00% |
| 2023-09-30 | $0.46B | $0.16B | 34.95% |
| 2023-06-30 | $0.45B | $0.16B | 34.68% |
| 2023-03-31 | $0.44B | $0.16B | 36.45% |
| 2022-12-31 | $0.42B | $0.16B | 37.41% |
| 2022-09-30 | $0.42B | $0.16B | 37.32% |
| 2022-06-30 | $0.43B | $0.16B | 37.53% |
| 2022-03-31 | $0.43B | $0.16B | 37.67% |
| 2021-12-31 | $0.44B | $0.17B | 38.22% |
| 2021-09-30 | $0.42B | $0.17B | 39.47% |
| 2021-06-30 | $0.40B | $0.16B | 40.40% |
| 2021-03-31 | $0.38B | $0.16B | 41.05% |
| 2020-12-31 | $0.38B | $0.16B | 41.11% |
| 2020-09-30 | $0.38B | $0.15B | 40.11% |
| 2020-06-30 | $0.38B | $0.15B | 39.06% |
| 2020-03-31 | $0.41B | $0.16B | 38.42% |
| 2019-12-31 | $0.41B | $0.16B | 38.39% |
| 2019-09-30 | $0.41B | $0.16B | 38.11% |
| 2019-06-30 | $0.42B | $0.16B | 38.76% |
| 2019-03-31 | $0.42B | $0.16B | 39.52% |
| 2018-12-31 | $0.41B | $0.16B | 38.83% |
| 2018-09-30 | $0.41B | $0.16B | 39.27% |
| 2018-06-30 | $0.41B | $0.16B | 39.75% |
| 2018-03-31 | $0.40B | $0.16B | 38.71% |
| 2017-12-31 | $0.40B | $0.16B | 38.75% |
| 2017-09-30 | $0.39B | $0.15B | 37.89% |
| 2017-06-30 | $0.38B | $0.14B | 36.46% |
| 2017-03-31 | $0.37B | $0.13B | 36.51% |
| 2016-12-31 | $0.38B | $0.14B | 38.40% |
| 2016-09-30 | $0.40B | $0.16B | 39.39% |
| 2016-06-30 | $0.40B | $0.16B | 39.85% |
| 2016-03-31 | $0.41B | $0.16B | 39.90% |
| 2015-12-31 | $0.40B | $0.16B | 39.10% |
| 2015-09-30 | $0.39B | $0.15B | 38.92% |
| 2015-06-30 | $0.38B | $0.15B | 38.16% |
| 2015-03-31 | $0.38B | $0.14B | 37.63% |
| 2014-12-31 | $0.38B | $0.14B | 37.99% |
| 2014-09-30 | $0.38B | $0.14B | 38.40% |
| 2014-06-30 | $0.37B | $0.14B | 38.38% |
| 2014-03-31 | $0.35B | $0.13B | 37.11% |
| 2013-12-31 | $0.33B | $0.11B | 33.94% |
| 2013-09-30 | $0.31B | $0.10B | 32.15% |
| 2013-06-30 | $0.32B | $0.10B | 30.91% |
| 2013-03-31 | $0.33B | $0.11B | 32.13% |
| 2012-12-31 | $0.36B | $0.12B | 33.79% |
| 2012-09-30 | $0.39B | $0.14B | 34.69% |
| 2012-06-30 | $0.41B | $0.14B | 33.25% |
| 2012-03-31 | $0.38B | $0.13B | 34.46% |
| 2011-12-31 | $0.34B | $0.12B | 36.61% |
| 2011-09-30 | $0.28B | $0.11B | 39.44% |
| 2011-06-30 | $0.22B | $0.11B | 47.75% |
| 2011-03-31 | $0.21B | $0.11B | 50.24% |
| 2010-12-31 | $0.21B | $0.10B | 50.00% |
| 2010-09-30 | $0.21B | $0.10B | 47.85% |
| 2010-06-30 | $0.22B | $0.10B | 46.85% |
| 2010-03-31 | $0.22B | $0.10B | 45.66% |
| 2009-12-31 | $0.23B | $0.11B | 46.05% |
| 2009-09-30 | $0.23B | $0.11B | 47.16% |
| 2009-06-30 | $0.23B | $0.11B | 48.72% |
| 2009-03-31 | $0.23B | $0.11B | 50.44% |
| 2008-12-31 | $0.22B | $0.11B | 49.11% |
| 2008-09-30 | $0.22B | $0.11B | 50.00% |
| 2008-06-30 | $0.21B | $0.11B | 50.71% |
| 2008-03-31 | $0.20B | $0.11B | 51.47% |
| 2007-12-31 | $0.18B | $0.10B | 54.95% |
| 2007-09-30 | $0.16B | $0.09B | 55.77% |
| 2007-06-30 | $0.14B | $0.08B | 57.14% |
| 2007-03-31 | $0.11B | $0.06B | 55.36% |
| 2006-12-31 | $0.09B | $0.05B | 54.65% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.029B | $0.402B |
| Accuray Inc. designs, develops & sells radiosurgery and radiation therapy systems for treatment of tumors in the body. The company's product suite includes the CyberKnife Systems and the TomoTherapy Systems. It primarily generates revenues by selling the CyberKnife & TomoTherapy Systems and providing ongoing services and upgrades to customers following installation of the CyberKnife System. Product revenues include sales of linacs for other uses. It also offers optional hardware and software, technical enhancements and upgrades to the CyberKnife & TomoTherapy System. The CyberKnife Systems include: the CyberKnife G4, CyberKnife VSI System and the new CyberKnife M6 Series System. TomoTherapy Systems include the Hi-Art System, delivering CT-guided, helical intensity modulated radiation therapy; the TomoHD System and the Tomo H Series Systems. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $226.884B | 25.75 |
| Intuitive Surgical (ISRG) | United States | $133.518B | 45.26 |
| Edwards Lifesciences (EW) | United States | $49.242B | 30.43 |
| IQVIA Holdings (IQV) | United States | $43.729B | 23.39 |
| Waters (WAT) | United States | $40.283B | 29.97 |
| IDEXX Laboratories (IDXX) | United States | $40.144B | 35.83 |
| Alcon (ALC) | Switzerland | $33.505B | 20.78 |
| DexCom (DXCM) | United States | $31.955B | 33.21 |
| Mettler-Toledo (MTD) | United States | $25.762B | 28.65 |
| STERIS (STE) | Ireland | $20.832B | 20.50 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.759B | 0.00 |
| Hologic (HOLX) | United States | $16.752B | 17.53 |
| Coloplast (CLPBY) | Denmark | $14.762B | 17.70 |
| Penumbra (PEN) | United States | $12.599B | 83.08 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $12.279B | 8.59 |
| Globus Medical (GMED) | United States | $10.173B | 15.40 |
| Glaukos (GKOS) | United States | $10.092B | 0.00 |
| Masimo (MASI) | United States | $9.578B | 30.69 |
| SARTORIUS (SSSGY) | Germany | $7.521B | 43.67 |
| Sysmex ADR (SSMXY) | Japan | $7.390B | 27.95 |
| Teleflex (TFX) | United States | $5.521B | 14.89 |
| LivaNova (LIVN) | United Kingdom | $4.442B | 22.46 |
| Integer Holdings (ITGR) | United States | $4.287B | 19.86 |
| Pulse Biosciences (PLSE) | United States | $3.752B | 0.00 |
| Veracyte (VCYT) | United States | $3.313B | 27.11 |
| TransMedics (TMDX) | United States | $2.967B | 43.58 |
| AxoGen (AXGN) | United States | $2.354B | 0.00 |
| UFP Technologies (UFPT) | United States | $2.153B | 27.17 |
| Elekta AB (EKTAY) | Sweden | $1.883B | 17.62 |
| Nihon Kohden (NHNKY) | Japan | $1.694B | 15.52 |
| Alphatec Holdings (ATEC) | United States | $1.677B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $1.301B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.222B | 6.36 |
| Artivion (AORT) | United States | $1.217B | 46.24 |
| PROCEPT BioRobotics (PRCT) | United States | $1.204B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $1.171B | 27.77 |
| Tandem Diabetes Care (TNDM) | United States | $1.170B | 0.00 |
| OPKO Health (OPK) | United States | $1.164B | 0.00 |
| IRadimed (IRMD) | United States | $1.055B | 46.11 |
| Anteris Technologies Global (AVR) | Australia | $0.850B | 0.00 |
| SiBone (SIBN) | United States | $0.829B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.753B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.680B | 16.37 |
| AngioDynamics (ANGO) | United States | $0.641B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.583B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.570B | 1644.00 |
| Tactile Systems Technology (TCMD) | United States | $0.511B | 20.90 |
| NeuroPace (NPCE) | United States | $0.501B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.448B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.420B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.411B | 0.00 |
| 908 Devices (MASS) | United States | $0.402B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.371B | 0.00 |
| Mobia Medical (MOBI) | United States | $0.334B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.311B | 2.32 |
| Treace Medical Concepts (TMCI) | United States | $0.301B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.266B | 0.00 |
| RxSight (RXST) | United States | $0.254B | 0.00 |
| Neuronetics (STIM) | United States | $0.221B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.159B | 0.00 |
| FocalTherics (FOCL) | France | $0.154B | 0.00 |
| Inogen (INGN) | United States | $0.139B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.124B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.097B | 0.00 |
| LENSAR (LNSR) | United States | $0.096B | 0.00 |
| Hyperfine (HYPR) | United States | $0.085B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.083B | 0.00 |
| CVRx (CVRX) | United States | $0.080B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.078B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.071B | 23.27 |
| DarioHealth (DRIO) | United States | $0.069B | 0.00 |
| Positron (POSC) | United States | $0.059B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.059B | 0.00 |
| Envoy Medical (COCH) | United States | $0.056B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.055B | 0.00 |
| Spectral AI (MDAI) | United States | $0.052B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.052B | 0.00 |
| Precision Optics (POCI) | United States | $0.048B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.045B | 0.00 | |
| InspireMD (NSPR) | United States | $0.038B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.036B | 0.00 |
| PAVmed (PAVM) | United States | $0.035B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.032B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.010B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.009B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.007B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.004B | 0.00 |
| Tenon Medical (TNON) | United States | $0.004B | 0.00 |
| ENvue Medical (FEED) | United States | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| NexGel (NXGL) | United States | $0.003B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.000B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |